Patent Office Rejects AcelRX's Application for Nanotab Sufentanil - (18 Sep 2015)
Indian Patent Office has refused patent application of US-based AcelRx Pharmaceuticals, Inc, for a nanotab sufentanil,which is supposed to be administered below tongue rather than swallowing a larger pill for relief. Application failed to pass the test of Section 3(d) of Patent Act.
Tags : INDIAN PATENT OFFICE ACELRX NANOTAB SUFENTANIL
Share : 
|